Trial intelligence / Profile preview

Hydrocortisone enema for prevention of acute radiation proctitis

IRCT20230122057175N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, triple-blind trial in radiation proctitis comparing Hydrocortisone enema with Placebo enema (2 arms). Primary endpoints: Severity of proctitis, Severity of diarrhea and 4 more. Started Mar 2023; status: completed.

02

Drugs

hydrocortisone
03

Conditions

radiation proctitis

Beyond the preview

Go deeper on IRCT20230122057175N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230122057175N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call